Genomic characterization of SARS-CoV-2 from Islamabad, Pakistan by Rapid Nanopore sequencing
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Since the start of COVID-19 pandemic, Pakistan has experienced four waves of pandemic. The fourth wave ended in October, 2021 while the fifth wave of pandemic starts in January, 2022. The data regarding the circulating strains after the fourth wave of pandemic from Pakistan is not available. The current study explore the genomic diversity of SARS-CoV-2 after fourth wave and before fifth wave of pandemic through whole genome sequencing. The results showed the circulation of different strains of SARS-CoV-2 during November-December, 2021. We have Omicron BA.1 (n=4), Lineage A (n=2) and delta AY.27 (n=1) variants of SARS-CoV-2 in the population of Islamabad. All the isolates harbors characteristics mutations of omicron and delta variant in the genome. The lineage A isolate harbors a nine amino acid (68-76) and a ten amino acid (679-688) deletion in the genome. The circulation of omicron in the population before the fifth wave of pandemic and subsequent upsurges of COVID-19 positive cases in Pakistan highlights the importance of genomic surveillance.
Article activity feed
-
SciScore for 10.1101/2022.02.17.480826: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The National Institute of Health’s Internal Review Board accepted the study design, and the datasets were anonymised and free of personally identifiable information. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources Samples were sequenced for 72 hours using FLO-MIN106 flowcells on MinION MK1b sequencing equipment with high sequence basecalling enabled using MinKNOW (Version 4.2.8, Oxford Nanopore Technologies). MinIONsuggested: (MinION, RRID:SCR_017985)Read length filtering and reference alignment to the Wuhan-Hu-1 genome were used to test variant polishing in … SciScore for 10.1101/2022.02.17.480826: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The National Institute of Health’s Internal Review Board accepted the study design, and the datasets were anonymised and free of personally identifiable information. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources Samples were sequenced for 72 hours using FLO-MIN106 flowcells on MinION MK1b sequencing equipment with high sequence basecalling enabled using MinKNOW (Version 4.2.8, Oxford Nanopore Technologies). MinIONsuggested: (MinION, RRID:SCR_017985)Read length filtering and reference alignment to the Wuhan-Hu-1 genome were used to test variant polishing in Nanopolish v0.13.2, Medaka v0.11.5, and samtools 1.9. Nanopolishsuggested: (Nanopolish, RRID:SCR_016157)samtoolssuggested: (SAMTOOLS, RRID:SCR_002105)Genomic dataset and Phylogenetic classification: For phylogenetic tree NCBI BLAST search of the study isolates were performed in order to get closely related sequence of SARS-CoV-2. BLASTsuggested: (BLASTX, RRID:SCR_001653)For multiple sequence alignment MAFFT software was used. MAFFTsuggested: (MAFFT, RRID:SCR_011811)For substitution model prediction jModelTest was used, Maximum Likelihood (ML) phylogenetic tree was build using IQtree (http://www.iqtree.org/). IQtreesuggested: Nonehttp://www.iqtree.org/suggested: (IQ-TREE, RRID:SCR_017254)The tree was edited and visualized using Figtree software (http://tree.bio.ed.ac.uk/software/figtree/). Figtreesuggested: (FigTree, RRID:SCR_008515)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-